Skip to main content
. 2017 Aug 24;12:144. doi: 10.1186/s13023-017-0693-2

Fig. 4.

Fig. 4

Change in % predicted MIP at week 72. Individual subject change from baseline after receiving 20 mg/kg reveglucosidase alfa intravenously every 2 weeks. Abbreviation: MIP, maximal inspiratory pressure